Cargando…
Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors
Carvedilol is reported to prevent cancers in humans and animal models. However, a molecular mechanism has yet to be established, and the extent to which other β-blockers are chemopreventive remains relatively unknown. A comparative pharmacological approach was utilized with the expectation that a me...
Autores principales: | Cleveland, Kristan H., Liang, Sherry, Chang, Andy, Huang, Kevin M., Chen, Si, Guo, Lei, Huang, Ying, Andresen, Bradley T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527222/ https://www.ncbi.nlm.nih.gov/pubmed/31107911 http://dx.doi.org/10.1371/journal.pone.0217038 |
Ejemplares similares
-
How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022) -
Reply to: How carvedilol does not activate β(2)-adrenoceptors
por: Kostenis, Evi, et al.
Publicado: (2023) -
How carvedilol does not activate β(2)-adrenoceptors
por: Lefkowitz, Robert J., et al.
Publicado: (2023) -
The β-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin
por: Chen, Mengbing, et al.
Publicado: (2020) -
Crystal Structures of a Stabilized β(1)-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol
por: Warne, Tony, et al.
Publicado: (2012)